Tuberculosis Diagnostics Market By Test Type (Radiographic Methods, Laboratory Methods, Nucleic Acid Testing, Phage Assay, Cytokine Detection Test, Detection Of Drug Resistance, Mantoux Test) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025
This report on global tuberculosis diagnostics market studies various tuberculosis diagnostics test type. Healthcare regulatory agencies such as WHO, CDC are taking initiatives towards global awareness of tuberculosis and improvising the diagnostic methods. Large patient pool suffering with tuberculosis, rising public awareness regarding tuberculosis and early diagnosis and technological advancement in the testing methods such as Mantoux test, and Cytokine detection test are the driving factors for the tuberculosis diagnostics market.
For the purpose of this study, the various test types of tuberculosis diagnostics studied include radiography methods, laboratory methods, nucleic acid testing, phage assay, cytokine detection test, detection of drug resistance and Mantoux test. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.
The geographic segmentation of the global tuberculosis diagnostics market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of, cross-sectional study by test type and major countries.
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Rest of LATAM
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global tuberculosis diagnostics market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global tuberculosis diagnostics market. The key players profiled in this report are Abbott laboratories, Alere Inc., Becton Dickinson and Company, bioMérieux SA, Cepheid Inc., Epistem plc, F.Hoffman La Roche Ltd., Hain Lifescience GmbH, Hologic Corporation, Thermo Fisher Scientific, Inc. and QIAGEN.
Based on test type, the global tuberculosis diagnostics market is categorized into
- Radiographic Methods
- Laboratory Methods
- Smear Microscopy
- Culture Based Test
- Nucleic Acid Testing
- Phage Assay
- Cytokine Detection Test
- Detection Of Drug Resistance
- Mantoux Test
Tuberculosis is one of the leading cause of death worldwide, according to the World Health Organization in 2013 around 9 million new cases of tuberculosis were reported with approximately 1.5 million deaths. The tuberculosis diagnostic market segment is driven by factors such as increasing diagnosis rate in the high prevalence regions, advanced technologies such as radiographic methods and cytokine detection test, cost efficient diagnostic tests are in demand and launching of technologically advanced diagnostic kits. In 2016 laboratory diagnostics held the largest market share in the test type segment chiefly due to factors such as rising prevalence of tuberculosis they are affordable and very easy to perform. The restraints of the laboratory diagnostic test are compromised accuracy and the long incubation period required for the interpretation of diagnosis. Nucleic acid test and Mantoux test will be the fastest growing market throughout the forecast period 2017-2025 due to key market drivers such as advanced techniques, less incubation period required for interpretation of the diagnosis performed, and high accuracy. The major players involved the manufacturing of the diagnostic kits and equipment are Alere, Inc. Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, F.Hoffman La Roche AG, Qiagen, BioMerieux SA, Cephied, Inc., Epistem plc., Hain Lifescience GmbH and Hologic Corporation.
For the purpose of this study, the global tuberculosis diagnostics market is categorized into:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
North America will be the fastest growing market for tuberculosis diagnostics throughout the forecast period 2017-2025. According to the Centers for Disease Control and Prevention, approximately 9,557 new cases of TB were reported in 2015, the market growth is mainly attributed to rising public awareness of tuberculosis leading to early diagnosis, evolved reimbursement scenario, and developed healthcare infrastructure. According to the World Health Organization (WHO) in 2015, 323,000 new TB cases were reported in Europe i.e. approximately 900 people suffered with TB each day. Europe is expected to be the second largest market due to rising prevalence of MDR-TB, government & non-government organizations grants to strengthen R&D facilities to launch novel tuberculosis diagnostics testing kits, and supportive regulatory approval for tuberculosis diagnostics market. In base year 2016, Asia Pacific was observed as the leading market for tuberculosis diagnostics due to factors such as rising prevalence of tuberculosis, according to World Health Organization in South East Asia annually 2 million people are diagnosed with TB, competitive market due to manufactures involved in tuberculosis diagnostic kit production, increasing disposable income in these regions and government and non-government initiatives to mitigate tuberculosis as per TB programmes. However, factors such as developing health infrastructure, increasing awareness about tuberculosis diagnostics are going to fuel the rapid growth of tuberculosis diagnostics market in Latin America and Middle East and Africa region in the near future.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Tuberculosis Diagnostics Market Portraiture
2.2 Global Tuberculosis Diagnostics Market, by Test Type 2016 Vs 2025 (US$ Mn)
2.3 Global Tuberculosis Diagnostics Market, by Geography, 2016 (Value %)
Chapter 3 Global Tuberculosis Diagnostics Market: Market Dynamics and Future Outlook
3.1 Overview
3.2 Market Drivers
3.2.1 Rising prevalence of Tuberculosis
3.2.2 For a full, detailed list, browse our report
3.3 Market Restraints
3.3.1 Costly diagnosis and lack of skilled labor to perform accurate diagnosis will hinder the growth of tuberculosis diagnostic market
3.3.2 For a full, detailed list, browse our report
3.4 Market Opportunities
3.4.1 Increasing number of patients reported with MDR-TB and hospital acquired infection
3.4.2 For a full, detailed list, browse our report
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Global Tuberculosis Diagnostics Market, by Key Players
Chapter 4 Global Tuberculosis Diagnostics Market, by Test Type, 2015-2025 (US$ Mn)
4.1 Introduction
4.2 Radiographic Methods
4.3 Laboratory Methods
4.3.1 Smear Microscopy
4.3.2 Culture Based Test
4.4 Nucleic Acid Testing
4.5 Phage Assay
4.6 Cytokine Detection Test
4.7 Detection of Drug Resistance
4.8 Mantoux Test
Chapter 5 Global Tuberculosis Diagnostics Market, by Geography, 2015-2025 (US$ Mn)
5.1 Preface
5.2 North America
5.2.1 North America Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.2.2 North America Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.2.2.1 U.S.
5.2.2.2 Canada
5.3 Europe
5.3.1 Europe Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.3.2 Europe Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.3.2.1 U.K.
5.3.2.2 Germany
5.3.2.3 Rest of Europe
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Diagnostics Market, by Test Type, 2015-2025 (US$ Mn)
5.4.2 Asia Pacific Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.4.2.1 China
5.4.2.2 Japan
5.4.2.3 Rest of Asia Pacific
5.5 Latin America
5.5.1 Latin America Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.5.2 Latin America Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.5.2.1 Brazil
5.5.2.2 Mexico
5.5.2.3 Rest of Latin America
5.6 Middle East and Africa
5.6.1 Middle East and Africa Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.6.2 Middle East and Africa Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.6.2.1 GCC
5.6.2.2 Rest of Middle East and Africa
Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Alere, Inc.
6.3 Becton Dickinson and Company
6.4 bioMérieux SA
6.5 Cepheid Inc.
6.6 Epistem plc
6.7 F. Hoffman La Roche AG
6.8 Hain Lifescience GmbH
6.9 Hologic Corporation
6.10 Thermo Fisher Scientific, Inc.
6.11 QIAGEN
TABLE 1 Global Tuberculosis Diagnostics Market, By Test Type, 2015-2025 (US$ Mn)
TABLE 2 Global Tuberculosis Diagnostics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America Tuberculosis Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 4 North America Tuberculosis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 5 Europe Tuberculosis Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Tuberculosis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Asia Pacific Tuberculosis Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 8 Asia Pacific Tuberculosis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Latin America Tuberculosis Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America Tuberculosis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Middle East and Africa Tuberculosis Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 12 Middle East and Africa Tuberculosis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Abbott Laboratories: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 14 Alere, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 15 Becton Dickinson and Company: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 16 bioMérieux SA.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 17 Cepheid Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 18 Epistem plc: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 19 F. Hoffman La Roche AG: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 20 Hain Lifescience GmbH: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 21 Hologic Corporation: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 22 Thermo Fisher Scientific Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
TABLE 23 QIAGEN: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
FIG. 1 Global Tuberculosis Diagnostics Market: Research Methodology
FIG. 2 Global Tuberculosis Diagnostics Market, by Test Type, 2016 (US$ Mn)
FIG. 3 Global Tuberculosis Diagnostics Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography, 2016
FIG. 5 Market Positioning of Key Tuberculosis Diagnostics Vendors, 2016
FIG. 6 Radiographic Methods Market, 2015 – 2025 (US$ Mn)
FIG. 7 Laboratory Methods Market, 2015 – 2025 (US$ Mn)
FIG. 8 Nucleic Acid Testing Market, 2015 – 2025 (US$ Mn)
FIG. 9 Phage Assay Market, 2015 – 2025 (US$ Mn)
FIG. 10 Cytokine Detection Test Market, 2015 – 2025 (US$ Mn)
FIG. 11 Detection of Drug Resistance Market, 2015 – 2025 (US$ Mn)
FIG. 12 Mantoux Test Market, 2015 – 2025 (US$ Mn)
FIG. 13 U.S. Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 14 Canada Tuberculosis Diagnostics Market, 2015– 2025 (US$ Mn)
FIG. 15 U.K. Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 16 Germany Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 17 Rest of Europe Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 18 China Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 20 Rest of Asia Pacific Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 21 Brazil Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 22 Mexico Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 23 Rest of Latin America Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 24 GCC Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest of Middle East and Africa Tuberculosis Diagnostics Market, 2015 – 2025 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)